Lau C P-Y, Poon R T-P, Cheung S-T, Yu W-C, Fan S-T
Centre for the Study of Liver Disease and Department of Surgery, The University of Hong Kong, Pokfulam, Hong Kong, China.
J Pathol. 2006 Dec;210(4):459-68. doi: 10.1002/path.2068.
Both Secreted Protein Acidic and Rich in Cysteine (SPARC) and Hevin are multifunctional matricellular glycoproteins. Recent experimental studies suggested that Hevin and SPARC together diminish angiogenesis, but their significance in hepatocellular carcinoma (HCC) remains unclear. This study aimed to correlate SPARC and Hevin expression with angiogenesis and clinicopathological features in HCC. SPARC and Hevin protein and mRNA expression in HCC specimens were assessed by immunostaining, immunoblotting, and quantitative reverse transcriptase-polymerase chain reaction. Tumour microvessel density (MVD) was assessed by CD34 immunostaining. The role of SPARC and Hevin in HCC was further assessed in an in vivo nude mice xenograft model. Both SPARC and Hevin mRNA levels were significantly higher in tumours than in non-tumourous livers. A significant correlation between tumour SPARC and Hevin mRNA levels was found. Moreover, SPARC protein localized in the tumour sinusoidal area correlated significantly with Hevin protein localized in HCC cells. Truncated forms of SPARC and Hevin proteins were detected in clinical samples. Truncated SPARC protein localized in the tumour sinusoidal area correlated significantly with tumour MVD. On the other hand, overexpression of full-length SPARC in tumour xenografts in athymic nude mice significantly delayed tumour growth, and this delay was related to a decrease in tumour angiogenesis. Expression of Hevin protein within HCC cells was related to the presence of tumour encapsulation and the absence of hepatitis B surface antigen in clinical samples. Overexpression of Hevin in tumour xenografts also significantly delayed tumour growth. In conclusion, this study has shown that SPARC and Hevin are upregulated in HCC compared with non-tumourous liver, and that they are inter-related at both mRNA and protein levels. Moreover, both SPARC and Hevin were related to HCC angiogenesis and tumour progression.
富含半胱氨酸的酸性分泌蛋白(SPARC)和He vin都是多功能基质细胞糖蛋白。最近的实验研究表明,Hevin和SPARC共同抑制血管生成,但其在肝细胞癌(HCC)中的意义仍不清楚。本研究旨在探讨SPARC和Hevin表达与HCC血管生成及临床病理特征的相关性。通过免疫染色、免疫印迹和定量逆转录聚合酶链反应评估HCC标本中SPARC和Hevin蛋白及mRNA表达。通过CD34免疫染色评估肿瘤微血管密度(MVD)。在体内裸鼠异种移植模型中进一步评估SPARC和Hevin在HCC中的作用。肿瘤中SPARC和Hevin的mRNA水平均显著高于非肿瘤肝脏。发现肿瘤SPARC和Hevin的mRNA水平之间存在显著相关性。此外,定位于肿瘤窦状隙区域的SPARC蛋白与定位于HCC细胞中的Hevin蛋白显著相关。在临床样本中检测到SPARC和Hevin蛋白的截短形式。定位于肿瘤窦状隙区域的截短SPARC蛋白与肿瘤MVD显著相关。另一方面,在无胸腺裸鼠的肿瘤异种移植中全长SPARC的过表达显著延迟了肿瘤生长,这种延迟与肿瘤血管生成减少有关。HCC细胞内Hevin蛋白的表达与临床样本中肿瘤包膜的存在和乙肝表面抗原的缺失有关。肿瘤异种移植中Hevin的过表达也显著延迟了肿瘤生长。总之,本研究表明,与非肿瘤肝脏相比,HCC中SPARC和Hevin表达上调,且它们在mRNA和蛋白质水平上相互关联。此外,SPARC和Hevin均与HCC血管生成和肿瘤进展有关。